Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Expect many former posters to crawl out of the woodwork

"... the reason those investments were made in the first place, was because of vocal shareholder demands..."

Actually, I believe that these investments were made as a result of Pohl's stated "umbrella" policy. A policy that was followed by the many subsequent CEO's and never changed.

Share
New Message
Please login to post a reply